Patents by Inventor Ja Kyung Yoo

Ja Kyung Yoo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230095520
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating cancer, wherein the pharmaceutical composition comprises a thiazole derivative or a pharmaceutically acceptable salt thereof. Specifically, the present invention relates to a pharmaceutical composition that selectively inhibits the activity of CDK7 to reduce side effects, and treats and prevents cancer by inhibiting the proliferation of all cancer cells, rather than being limited to specific cancer cells.
    Type: Application
    Filed: March 12, 2021
    Publication date: March 30, 2023
    Inventors: Kwang Ok Lee, Ja Kyung Yoo, Jun Hee Lee, Mijung Lee, Kangwoo Lee, Ji Eun Min
  • Patent number: 11084823
    Abstract: The present invention relates to a compound represented by the Chemical Formula 1 defined in the present specification, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions.
    Type: Grant
    Filed: March 19, 2018
    Date of Patent: August 10, 2021
    Assignee: Daewoong Pharmaceutical Co., Ltd.
    Inventors: In Woo Kim, Ja Kyung Yoo, Ji Duck Kim, Sun Ah Jun, Jun Hee Lee
  • Publication number: 20210130358
    Abstract: The present invention relates to a compound represented by the Chemical Formula 1 defined in the present specification, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions.
    Type: Application
    Filed: March 19, 2018
    Publication date: May 6, 2021
    Inventors: In Woo Kim, Ja Kyung Yoo, Ji Duck Kim, Sun Ah Jun, Jun Hee Lee
  • Patent number: 10947241
    Abstract: The present invention relates to a compound represented by Chemical Formula 1, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of cardiovascular diseases.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: March 16, 2021
    Assignee: Seoul National University Hospital
    Inventors: Ja Kyung Yoo, Nora Lee, Chun Ho Lee, Myunggi Jung, Hyo-Soo Kim
  • Patent number: 10597362
    Abstract: The present invention relates to a compound represented by Chemical Formula 1, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of cardiovascular diseases.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: March 24, 2020
    Assignee: Seoul National University Hospital
    Inventors: Ja Kyung Yoo, Nora Lee, Chun Ho Lee, Hyo-Soo Kim
  • Publication number: 20190256465
    Abstract: The present invention relates to a compound represented by Chemical Formula 1, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of cardiovascular diseases.
    Type: Application
    Filed: October 27, 2017
    Publication date: August 22, 2019
    Inventors: Ja Kyung Yoo, Nora Lee, Chun Ho Lee, Hyo-Soo Kim
  • Publication number: 20190241574
    Abstract: The present invention relates to a compound represented by Chemical Formula 1, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of cardiovascular diseases.
    Type: Application
    Filed: October 27, 2017
    Publication date: August 8, 2019
    Inventors: Ja Kyung Yoo, Nora Lee, Chun Ho Lee, Myunggi Jung, Hyo-Soo Kim
  • Patent number: 10081634
    Abstract: The present invention relates to a compound represented by chemical formula 1, which can be used for the prevention and treatment of diseases caused by abnormality in a prolyl-tRNA synthetase (PRS) activity, or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition comprising the same.
    Type: Grant
    Filed: June 23, 2015
    Date of Patent: September 25, 2018
    Assignee: Daewoong Pharmaceutical Co., Ltd.
    Inventors: Joon Seok Park, Youn Jung Yoon, Min Jae Cho, Ho Bin Lee, Ja Kyung Yoo, Yong Lee Bong
  • Patent number: 10011586
    Abstract: The present invention relates to a heterocyclic compound having a novel structure that can be used in the prevention or treatment of diseases caused by abnormality in a PRS (prolyl-tRNA synthetase) activity, a method for preparing the same, and a pharmaceutical composition comprising the same.
    Type: Grant
    Filed: June 7, 2016
    Date of Patent: July 3, 2018
    Assignee: Daewoong Pharmaceutical Co., Ltd.
    Inventors: Joon Seok Park, Youn Jung Yoon, Min Jae Cho, Ho Bin Lee, Ja Kyung Yoo, Bong Yong Lee
  • Publication number: 20180044322
    Abstract: The present invention relates to a heterocyclic compound having a novel structure that can be used in the prevention or treatment of diseases caused by abnormality in a PRS (prolyl-tRNA synthetase) activity, a method for preparing the same, and a pharmaceutical composition comprising the same.
    Type: Application
    Filed: June 7, 2016
    Publication date: February 15, 2018
    Inventors: Joon Seok Park, Youn Jung Yoon, Min Jae Cho, Ho Bin Lee, Ja Kyung Yoo, Bong Yong Lee
  • Publication number: 20170088551
    Abstract: The present invention relates to a compound represented by chemical formula 1, which can be used for the prevention and treatment of diseases caused by abnormality in a prolyl-tRNA synthetase (PRS) activity, or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition comprising the same.
    Type: Application
    Filed: June 23, 2015
    Publication date: March 30, 2017
    Applicant: Daewoong Pharmaceutical., Ltd.
    Inventors: Joon Seok Park, Youn Jung Yoon, Min Jae Cho, Ho Bin Lee, Ja Kyung Yoo, Yong Lee Bong